富士製薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/03/12 | 1,800 | 1,808 | 1,781 | 1,786 | +1 | +0.1% | 20,300 |
2019/03/11 | 1,777 | 1,788 | 1,734 | 1,785 | +35 | +2% | 35,200 |
2019/03/08 | 1,799 | 1,800 | 1,750 | 1,750 | -89 | -4.8% | 23,600 |
2019/03/07 | 1,803 | 1,843 | 1,803 | 1,839 | +25 | +1.4% | 31,400 |
2019/03/06 | 1,831 | 1,843 | 1,808 | 1,814 | -26 | -1.4% | 22,600 |
2019/03/05 | 1,853 | 1,853 | 1,822 | 1,840 | -33 | -1.8% | 14,900 |
2019/03/04 | 1,915 | 1,915 | 1,873 | 1,873 | -27 | -1.4% | 14,800 |
2019/03/01 | 1,866 | 1,912 | 1,866 | 1,900 | +21 | +1.1% | 16,100 |
2019/02/28 | 1,902 | 1,909 | 1,867 | 1,879 | -43 | -2.2% | 22,700 |
2019/02/27 | 1,871 | 1,924 | 1,871 | 1,922 | +59 | +3.2% | 41,700 |
2019/02/26 | 1,880 | 1,892 | 1,858 | 1,863 | -17 | -0.9% | 12,000 |
2019/02/25 | 1,878 | 1,886 | 1,866 | 1,880 | +18 | +1% | 20,500 |
2019/02/22 | 1,856 | 1,891 | 1,844 | 1,862 | +6 | +0.3% | 36,500 |
2019/02/21 | 1,871 | 1,927 | 1,855 | 1,856 | +12 | +0.7% | 60,400 |
2019/02/20 | 1,781 | 1,849 | 1,781 | 1,844 | +48 | +2.7% | 28,800 |
2019/02/19 | 1,794 | 1,817 | 1,784 | 1,796 | +6 | +0.3% | 15,800 |
2019/02/18 | 1,798 | 1,798 | 1,774 | 1,790 | +25 | +1.4% | 15,100 |
2019/02/15 | 1,770 | 1,781 | 1,746 | 1,765 | -11 | -0.6% | 10,000 |
2019/02/14 | 1,781 | 1,819 | 1,771 | 1,776 | -5 | -0.3% | 18,900 |
2019/02/13 | 1,774 | 1,814 | 1,770 | 1,781 | -2 | -0.1% | 26,200 |
2019/02/12 | 1,702 | 1,783 | 1,702 | 1,783 | +112 | +6.7% | 32,400 |
2019/02/08 | 1,750 | 1,750 | 1,669 | 1,671 | -148 | -8.1% | 69,300 |
2019/02/07 | 1,793 | 1,830 | 1,788 | 1,819 | +7 | +0.4% | 21,400 |
2019/02/06 | 1,837 | 1,837 | 1,804 | 1,812 | -26 | -1.4% | 20,900 |
2019/02/05 | 1,839 | 1,842 | 1,797 | 1,838 | -7 | -0.4% | 20,000 |
2019/02/04 | 1,814 | 1,846 | 1,814 | 1,845 | +44 | +2.4% | 20,900 |
2019/02/01 | 1,774 | 1,810 | 1,771 | 1,801 | +21 | +1.2% | 23,400 |
2019/01/31 | 1,788 | 1,820 | 1,771 | 1,780 | -2 | -0.1% | 15,500 |
2019/01/30 | 1,800 | 1,815 | 1,780 | 1,782 | -23 | -1.3% | 28,700 |
2019/01/29 | 1,757 | 1,814 | 1,757 | 1,805 | +38 | +2.2% | 19,100 |
2019/01/28 | 1,779 | 1,799 | 1,762 | 1,767 | -9 | -0.5% | 13,600 |
2019/01/25 | 1,816 | 1,817 | 1,776 | 1,776 | -20 | -1.1% | 13,600 |
2019/01/24 | 1,809 | 1,819 | 1,795 | 1,796 | -13 | -0.7% | 7,100 |
2019/01/23 | 1,772 | 1,824 | 1,764 | 1,809 | +19 | +1.1% | 20,800 |
2019/01/22 | 1,813 | 1,825 | 1,779 | 1,790 | -23 | -1.3% | 15,000 |
2019/01/21 | 1,813 | 1,828 | 1,810 | 1,813 | +4 | +0.2% | 9,800 |
2019/01/18 | 1,797 | 1,838 | 1,797 | 1,809 | +11 | +0.6% | 18,700 |
2019/01/17 | 1,779 | 1,801 | 1,770 | 1,798 | +26 | +1.5% | 11,800 |
2019/01/16 | 1,769 | 1,805 | 1,765 | 1,772 | -17 | -1% | 25,700 |
2019/01/15 | 1,786 | 1,817 | 1,772 | 1,789 | -24 | -1.3% | 22,100 |
2019/01/11 | 1,813 | 1,827 | 1,770 | 1,813 | ±0 | ±0% | 21,500 |
2019/01/10 | 1,765 | 1,824 | 1,765 | 1,813 | +11 | +0.6% | 28,200 |
2019/01/09 | 1,809 | 1,825 | 1,791 | 1,802 | +1 | +0.1% | 31,000 |
2019/01/08 | 1,810 | 1,817 | 1,780 | 1,801 | -17 | -0.9% | 31,100 |
2019/01/07 | 1,859 | 1,888 | 1,800 | 1,818 | +10 | +0.6% | 24,600 |
2019/01/04 | 1,730 | 1,819 | 1,700 | 1,808 | +38 | +2.1% | 35,400 |
2018/12/28 | 1,817 | 1,833 | 1,754 | 1,770 | -44 | -2.4% | 20,300 |
2018/12/27 | 1,702 | 1,850 | 1,702 | 1,814 | +176 | +10.7% | 37,600 |
2018/12/26 | 1,615 | 1,660 | 1,615 | 1,638 | +31 | +1.9% | 19,600 |
2018/12/25 | 1,661 | 1,678 | 1,603 | 1,607 | -129 | -7.4% | 31,800 |
1351~
1400
件表示中 / 6797件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
富士製薬 | 129,900円 | +12.7% | +1.8% | 3.27% | 5.10倍 | 0.72倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
ダイト | 226,700円 | +4.5% | -10.8% | 3.09% | 15.08倍 | 0.67倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ハートシード | 163,800円 | -55.5% | - | 0.00% | - | 8.03倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ミズホメディ | 157,500円 | -5.1% | -21.2% | 5.08% | 9.95倍 | 1.90倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ステムリム | 44,000円 | - | - | 0.00% | - | 3.57倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム